Skip to main content
. Author manuscript; available in PMC: 2013 May 23.
Published in final edited form as: Antivir Ther. 2012 Mar 13;17(4):737–743. doi: 10.3851/IMP2087

Table 1.

Baseline characteristics

Variables Cohort 1: d4T 40mg
(n=235)
Cohort 2: d4T 30mg
(n=240)
P-Value
Age (mean, SD) 34 (8.3) 33 (9.0) 0.20
Female Sex 169 (71.5%) 163 (67.2%) 0.40
Nadir CD4 count cells/uL; median (range) 120 (2–391) 135 (2–648) 0.39
Log HIV-1Viral Load median copies/ml (range) 5.1 (2.6 – 6.6) 5.1 (1.6 – 6.9) 0.12
Weight kg mean (range/SD) 66.2 (42–111/10.5) 56.4 (31–84/10.0) <0.0001
BMI kg/m2 (range) 24.8 (14.5 – 49.3) 22.8 (12.6 – 42.6) <0.0001
History of TB Treatment 47 (20.4%) 64 (26.6%) 0.13
Current TB Treatment 42 (18.3%) 95 (39.8%) <0.0001
Highest Grade of PN:
  Grade1 60 20
  Grade2 82 72
  Grade3 8 8
  Grade4 6 1